首页> 外文OA文献 >Metabolic engineering approaches reveal widespread physiological functions of membrane lipids for Saccharomyces cerevisiae
【2h】

Metabolic engineering approaches reveal widespread physiological functions of membrane lipids for Saccharomyces cerevisiae

机译:代谢工程学方法揭示了酿酒酵母中膜脂的广泛生理功能

摘要

The lipid composition of biological membranes can differ significantly between organisms and even between organelles of the same cell in terms of lipid compounds and specific ratios of lipid classes. Referring to this, every membrane features a characteristic lipid composition that is thought to regulate its physicochemical properties and cellular function by providing lipid environments supporting the integrity of membrane-localized protein machinery and membrane-associated processes. Chapter I gives a brief overview of the interlinkage between the chemical nature of membrane lipids, the structural and functional organization as well as the physicochemical properties of lipid bilayers and their influence on membrane-embedded proteins.udStudies to gain detailed knowledge on how membrane lipid composition influences the physiology of cells and regulates cellular processes require tools to manipulate lipid composition in vivo. By employing metabolic engineering approaches based on titratable gene expression tools, sets of Saccharomyces cerevisiae strains in which membrane lipid composition is under experimental control were engineered. The study described in Chapter II addresses OLE1, encoding for the sole fatty acid desaturase of budding yeast, to control the extent of acyl unsaturation of fatty acids incorporated in phospholipids. This approach revealed cellular roles for the physical state of cell membranes, so called membrane fluidity, on yeast flocculation and hypoxic growth. It is shown, how the endogenous lipid homeostasis machinery of budding yeast is adapted to carry out a broad response to oxygen limitation (hypoxia) and how it activates a non-canonical yeast flocculation pathway involving FLO1, which encodes for cell wall glycoproteins that mediate cell-cell-interactions by binding cell wall mannose residues of adjacent cells.udIn Chapter III, the previously generated strain in which expression of OLE1 is under experimental control was used as a cellular platform to assay the activity of heterologously expressed stearoyl-CoA desaturases (SCDs). Putative SCDs from human pathogens T. brucei and T. cruzi were functionally expressed in S. cerevisiae, thereby additionally confirming their SCD activity in vivo. The presented assay might also provide a tool to screen for inhibitors of SCDs, which are interesting drug targets in the treatment of bacterial and parasitic infections in humans.udThe study presented in Chapter IV addresses ERG9, an essential gene involved in the ergosterol biosynthetic pathway and used a metabolic engineering approach to achieve control over the total sterol biosynthetic activity of the cell. Cells that allowed for manipulating the native sterol homeostasis were employed to unveil physiological effects of ergosterol and total sterol depletion on the cell’s general viability as well as on fundamental membrane associated processes such as protein sorting and endo- and exocytosis. By combining this metabolic engineering approach and the powerful method of marker-free CRISPR/Cas9-mediated gene tagging, it was possible to establish a cellular system for investigating the impact of sterol depletion on the lateral distribution pattern of lipid-raft associated GFP-tagged membrane proteins within the plasma membrane of yeast.udChapter V introduces a novel set of all-in-one constitutive and inducible CRISPR/Cas9 vectors that allow for a very easy and highly convenient application of the technology in S. cerevisiae. The simplicity of the inducible system is based on the possibility of introducing a desired gRNA targeting sequence with homologous recombination-mediated assembly of overlapping single-stranded oligonucleotides. The inducible Cas9 expression approach also introduces the novel concept of chronologically separating the cloning procedure from the actual genome editing step by preloading cells with an all-in-one CRISPR/Cas9 plasmid. This way, CRISPR/Cas9-supported genome editing can be obtained with high efficiency and effectivity by just transforming a desired preloaded target strain with donor DNA to be genomically integrated without the need of co-introducing any of the CRISPR system components. These novel CRISPR/Cas9 systems will help to overcome limitations often observed for challenging metabolic and genetic engineering approaches that can be e.g. used for following studies to reveal physiological roles of membrane lipids for budding yeast.
机译:就脂质化合物和脂质类别的特定比例而言,生物膜之间的生物膜脂质组成可能会显着不同,甚至同一细胞的细胞器之间也可能存在显着差异。参照此,每个膜都具有特征性的脂质成分,该脂质成分被认为通过提供支持膜局部蛋白机制和膜相关过程完整性的脂质环境来调节其理化性质和细胞功能。第一章简要概述了膜脂质的化学性质,脂质双层的结构和功能组织以及理化性质及其对膜包埋蛋白的影响之间的相互联系。组成影响细胞的生理并调节细胞过程需要在体内操纵脂质组成的工具。通过使用基于可滴定基因表达工具的代谢工程方法,设计了膜脂质成分处于实验控制下的酿酒酵母菌株集。第二章中所述的研究针对OLE1,其编码发芽酵母的唯一脂肪酸去饱和酶,以控制磷脂中所含脂肪酸的酰基不饱和度。这种方法揭示了细胞在酵母絮凝和低氧生长中对细胞膜物理状态的作用,即所谓的膜流动性。结果表明,发芽酵母的内源脂质稳态机制如何适应对氧限制(缺氧)的广泛反应,以及它如何激活涉及FLO1的非经典酵母絮凝途径,该途径编码介导细胞的细胞壁糖蛋白通过结合相邻细胞的细胞壁甘露糖残基进行细胞相互作用。 ud在第三章中,先前产生的OLE1表达处于实验控制之下的菌株被用作细胞平台,以分析异源表达的硬脂酰CoA去饱和酶的活性( SCD)。来自人类病原体布鲁氏菌和克鲁斯氏菌的推定SCD在酿酒酵母中功能性表达,从而进一步证实了它们在体内的SCD活性。提出的检测方法也可能提供筛选SCD抑制剂的工具,SCD抑制剂是治疗人类细菌和寄生虫感染的有趣药物靶标。 ud第四章中的研究针对ERG9,这是一种与麦角固醇生物合成途径有关的必需基因并使用代谢工程方法来控制细胞的总固醇生物合成活性。允许操纵天然固醇稳态的细胞被用来揭示麦角固醇和总固醇消耗对细胞总体生存力以及基本膜相关过程(如蛋白质分选和胞吞和胞吐作用)的生理影响。通过结合这种代谢工程方法和无标记的CRISPR / Cas9介导的基因标记的强大方法,可以建立一个细胞系统,以研究固醇消耗对脂筏相关GFP标记的横向分布模式的影响。 udChapter V引入了一套新颖的全组成型和可诱导性CRISPR / Cas9载体,可在啤酒酵母中非常轻松,非常方便地应用该技术。可诱导系统的简单性基于引入具有重叠重组单链寡核苷酸的同源重组介导的组装的所需gRNA靶向序列的可能性。可诱导的Cas9表达方法还引入了一种新颖的概念,即通过将多合一CRISPR / Cas9质粒预加载细胞,从时间上将克隆程序与实际的基因组编辑步骤分开。这样,仅需用供体DNA进行基因组整合的供体DNA即可转化所需的预加载靶菌株,而无需共同引入任何CRISPR系统组件,就可以高效,高效地获得CRISPR / Cas9支持的基因组编辑。这些新颖的CRISPR / Cas9系统将有助于克服通常在挑战性代谢和基因工程方法方面经常遇到的局限性,例如用于后续研究,以揭示膜脂对发芽酵母的生理作用。

著录项

  • 作者

    Degreif Daniel;

  • 作者单位
  • 年度 2018
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号